ID   HIRP3_HUMAN             Reviewed;         556 AA.
AC   Q9BW71; H3BSR3; O75707; O75708;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   15-MAR-2017, entry version 134.
DE   RecName: Full=HIRA-interacting protein 3;
GN   Name=HIRIP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INTERACTION
RP   WITH HIRA, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9710638; DOI=10.1128/MCB.18.9.5546;
RA   Lorain S., Quivy J.-P., Monier-Gavelle F., Scamps C., Lecluse Y.,
RA   Almouzni G., Lipinski M.;
RT   "Core histones and HIRIP3, a novel histone-binding protein, directly
RT   interact with WD repeat protein HIRA.";
RL   Mol. Cell. Biol. 18:5546-5556(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH CK2,
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=17391060; DOI=10.1515/BC.2007.045;
RA   Assrir N., Filhol O., Galisson F., Lipinski M.;
RT   "HIRIP3 is a nuclear phosphoprotein interacting with and
RT   phosphorylated by the serine-threonine kinase CK2.";
RL   Biol. Chem. 388:391-398(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-142; SER-143;
RP   SER-159; SER-160; SER-196; SER-199; SER-223; SER-227; SER-289 AND
RP   SER-291, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-84; SER-87; SER-196;
RP   SER-227 AND SER-370, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-100; SER-159;
RP   SER-160; SER-223; SER-227; SER-330; SER-332; SER-333; SER-357;
RP   THR-358; SER-359; SER-363 AND SER-372, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-125; SER-196;
RP   SER-223 AND SER-227, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-159; SER-160;
RP   SER-196; SER-199; SER-227; SER-289; SER-291; SER-330; SER-332;
RP   SER-333; SER-550; SER-551 AND SER-555, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-142; SER-143;
RP   SER-159; SER-160; SER-196; SER-199; SER-223; SER-227; SER-289;
RP   SER-291; SER-330; SER-332; SER-333; SER-357; THR-358; SER-359; SER-363
RP   AND SER-370, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-125; SER-159;
RP   SER-160; SER-196; SER-199; SER-223; SER-227; SER-289; SER-291;
RP   SER-330; SER-332; SER-333; SER-370; THR-471 AND SER-530, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-555, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May play a role in chromatin function and histone
CC       metabolism via its interaction with HIRA and histones.
CC       {ECO:0000269|PubMed:9710638}.
CC   -!- SUBUNIT: Interacts with HIRA. Weak interaction with histones H2B
CC       and H3. Interacts with CK2. {ECO:0000269|PubMed:17391060,
CC       ECO:0000269|PubMed:9710638}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17391060}.
CC       Note=Nuclear throughout the cell cycle and is excluded from
CC       condensed chromatin during mitosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BW71-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BW71-2; Sequence=VSP_003877;
CC       Name=3;
CC         IsoId=Q9BW71-3; Sequence=VSP_046024, VSP_046025;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoform 1 is predominant in
CC       skeletal muscle. Isoform 2 is predominant in liver and heart.
CC       {ECO:0000269|PubMed:9710638}.
CC   -!- PTM: Phosphorylated by CK2. {ECO:0000269|PubMed:17391060}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ223349; CAA11273.1; -; mRNA.
DR   EMBL; AJ223350; CAA11274.1; -; mRNA.
DR   EMBL; AJ223351; CAA11275.2; -; mRNA.
DR   EMBL; BX393533; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC093512; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000588; AAH00588.1; -; mRNA.
DR   CCDS; CCDS10664.1; -. [Q9BW71-1]
DR   CCDS; CCDS58449.1; -. [Q9BW71-3]
DR   RefSeq; NP_001184252.1; NM_001197323.1. [Q9BW71-3]
DR   RefSeq; NP_003600.2; NM_003609.4. [Q9BW71-1]
DR   UniGene; Hs.567370; -.
DR   ProteinModelPortal; Q9BW71; -.
DR   BioGrid; 114053; 33.
DR   IntAct; Q9BW71; 9.
DR   MINT; MINT-1411245; -.
DR   STRING; 9606.ENSP00000279392; -.
DR   iPTMnet; Q9BW71; -.
DR   PhosphoSitePlus; Q9BW71; -.
DR   BioMuta; HIRIP3; -.
DR   DMDM; 116242511; -.
DR   EPD; Q9BW71; -.
DR   MaxQB; Q9BW71; -.
DR   PaxDb; Q9BW71; -.
DR   PeptideAtlas; Q9BW71; -.
DR   PRIDE; Q9BW71; -.
DR   Ensembl; ENST00000279392; ENSP00000279392; ENSG00000149929. [Q9BW71-1]
DR   Ensembl; ENST00000564026; ENSP00000456824; ENSG00000149929. [Q9BW71-3]
DR   GeneID; 8479; -.
DR   KEGG; hsa:8479; -.
DR   UCSC; uc002dve.4; human. [Q9BW71-1]
DR   CTD; 8479; -.
DR   DisGeNET; 8479; -.
DR   GeneCards; HIRIP3; -.
DR   HGNC; HGNC:4917; HIRIP3.
DR   HPA; HPA051897; -.
DR   HPA; HPA063205; -.
DR   MIM; 603365; gene.
DR   neXtProt; NX_Q9BW71; -.
DR   OpenTargets; ENSG00000149929; -.
DR   PharmGKB; PA29294; -.
DR   eggNOG; ENOG410IZNK; Eukaryota.
DR   eggNOG; ENOG4111SS6; LUCA.
DR   GeneTree; ENSGT00390000014062; -.
DR   HOGENOM; HOG000112903; -.
DR   HOVERGEN; HBG066199; -.
DR   InParanoid; Q9BW71; -.
DR   OMA; EENPRRA; -.
DR   OrthoDB; EOG091G0CB9; -.
DR   PhylomeDB; Q9BW71; -.
DR   TreeFam; TF331753; -.
DR   GeneWiki; HIRIP3; -.
DR   GenomeRNAi; 8479; -.
DR   PRO; PR:Q9BW71; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000149929; -.
DR   CleanEx; HS_HIRIP3; -.
DR   Genevisible; Q9BW71; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0006333; P:chromatin assembly or disassembly; TAS:ProtInc.
DR   InterPro; IPR019098; Histone_chaperone_domain_CHZ.
DR   Pfam; PF09649; CHZ; 1.
DR   SMART; SM01082; CHZ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    556       HIRA-interacting protein 3.
FT                                /FTId=PRO_0000083989.
FT   COMPBIAS    129    253       Glu-rich.
FT   COMPBIAS    398    403       Poly-Ser.
FT   MOD_RES      27     27       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      84     84       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243}.
FT   MOD_RES      98     98       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     160    160       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     199    199       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     223    223       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     289    289       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     291    291       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     357    357       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     358    358       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     363    363       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     372    372       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     471    471       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     530    530       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     550    550       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     551    551       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     555    555       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     101    413       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9710638}.
FT                                /FTId=VSP_003877.
FT   VAR_SEQ     101    175       ESGSEASSPDYFGPPAKNGVAAEVSPAKEENPRRASKAVEE
FT                                SSDEERQRDLPAQRGEESSEEEEKGYKGKTRKKP -> GWL
FT                                RSPWRGPPGCDEAEALHSGLWCPSKLQEAVGLLLLTQGAPE
FT                                YPPGRTGSARHEGYPFPREVSGPEGAEGGGS (in
FT                                isoform 3). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_046024.
FT   VAR_SEQ     176    556       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_046025.
FT   VARIANT     496    496       A -> V (in dbSNP:rs35431046).
FT                                /FTId=VAR_051033.
FT   VARIANT     521    521       G -> W (in dbSNP:rs11643314).
FT                                /FTId=VAR_028115.
FT   CONFLICT     58     58       L -> P (in Ref. 1; CAA11273/CAA11274/
FT                                CAA11275 and 2). {ECO:0000305}.
SQ   SEQUENCE   556 AA;  61957 MW;  ACABE2E0032B8C13 CRC64;
     MAREKEMQEF TRSFFRGRPD LSTLTHSIVR RRYLAHSGRS HLEPEEKQAL KRLVEEELLK
     MQVDEAASRE DKLDLTKKGK RPPTPCSDPE RKRFRFNSES ESGSEASSPD YFGPPAKNGV
     AAEVSPAKEE NPRRASKAVE ESSDEERQRD LPAQRGEESS EEEEKGYKGK TRKKPVVKKQ
     APGKASVSRK QAREESEESE AEPVQRTAKK VEGNKGTKSL KESEQESEEE ILAQKKEQRE
     EEVEEEEKEE DEEKGDWKPR TRSNGRRKSA REERSCKQKS QAKRLLGDSD SEEEQKEAAS
     SGDDSGRDRE PPVQRKSEDR TQLKGGKRLS GSSEDEEDSG KGEPTAKGSR KMARLGSTSG
     EESDLEREVS DSEAGGGPQG ERKNRSSKKS SRKGRTRSSS SSSDGSPEAK GGKAGSGRRG
     EDHPAVMRLK RYIRACGAHR NYKKLLGSCC SHKERLSILR AELEALGMKG TPSLGKCRAL
     KEQREEAAEV ASLDVANIIS GSGRPRRRTA WNPLGEAAPP GELYRRTLDS DEERPRPAPP
     DWSHMRGIIS SDGESN
//
